Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	6.32B
Revenue (ttm)	3.95B
Net Income (ttm)	397.61M
Shares Out	2.00B
EPS (ttm)	0.20
PE Ratio	15.92
Forward PE	9.43
Dividend	0.04 (1.27%)
Ex-Dividend Date	Jul 8, 2025

Volume	5,746,725
Average Volume	5,526,274
Open	3.160
Previous Close	3.160
Day's Range	3.140 - 3.210
52-Week Range	2.304 - 3.687
Beta	0.14
RSI	49.42
Earnings Date	Mar 8, 2026

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.